Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-03 11:02 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Meditor Group Ltd | 3,791,300 3.300% |
-677,535 (-15.16%) |
Filing History |
| 2023-10-05 09:00 am Purchase |
2023-10-05 | 13G | Esperion Therapeutics, Inc. ESPR |
Two Seas Capital LP | 7,922,170 7.400% |
7,922,170 (New Position) |
Filing History |
| 2023-08-29 4:17 pm Purchase |
2023-08-28 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 5,366,452 5.000% |
143,013 (+2.74%) |
Filing History |
| 2023-08-28 4:13 pm Purchase |
2023-08-21 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 5,223,439 4.900% |
1,599,537 (+44.14%) |
Filing History |
| 2023-06-08 1:25 pm Sale |
2023-05-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BLACKROCK INC BLK |
4,645,359 4.900% |
-863,828 (-15.68%) |
Filing History |
| 2023-04-05 4:23 pm Purchase |
2023-04-04 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 4,533,756 5.000% |
2,095,618 (+85.95%) |
Filing History |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,194,064 5.700% |
-283,900 (-6.34%) |
Filing History |
| 2023-02-14 4:14 pm Sale |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 2,438,138 4.200% |
-1,032,140 (-29.74%) |
Filing History |
| 2023-02-14 11:14 am Sale |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
CVI Investments, Inc. | 5,500,000 6.900% |
-1,222,709 (-18.19%) |
Filing History |
| 2023-02-10 1:46 pm Purchase |
2023-02-10 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 9,801,161 12.800% |
462,115 (+4.95%) |
Filing History |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Esperion Therapeutics, Inc. ESPR |
The Vanguard Group | 4,260,464 5.780% |
499,025 (+13.27%) |
Filing History |
| 2023-02-07 1:06 pm Purchase |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BLACKROCK INC BLK |
5,509,187 7.500% |
3,267,970 (+145.81%) |
Filing History |
| 2023-01-20 4:13 pm Purchase |
2023-01-11 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 3,623,902 4.900% |
3,623,902 (New Position) |
Filing History |
| 2023-01-04 2:30 pm Unchanged |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Meditor Group Ltd | 4,468,835 6.100% |
0 (Unchanged) |
Filing History |
| 2022-08-23 4:59 pm Purchase |
2022-08-22 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 3,470,278 5.200% |
3,470,278 (New Position) |
Filing History |
| 2022-05-17 3:06 pm Sale |
2022-05-17 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 5,000,000 4.990% |
-5,000,000 (-50.00%) |
Filing History |
| 2022-02-14 3:19 pm Purchase |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
CVI Investments, Inc. | 6,722,709 9.900% |
448,324 (+7.15%) |
Filing History |
| 2022-02-11 4:39 pm Unchanged |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,477,964 7.100% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:09 pm Unchanged |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 10,000,000 8.060% |
0 (Unchanged) |
Filing History |
| 2022-02-11 2:54 pm Purchase |
2022-02-11 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 9,339,046 14.400% |
5,341,036 (+133.59%) |
Filing History |